Real-World study tracks myeloma Patients' adherence to carfilzomib combos
NCT ID NCT02970747
First seen Jan 04, 2026 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study looked at how consistently 359 adults with relapsed multiple myeloma followed their prescribed carfilzomib combination treatments in everyday medical practice. Researchers measured adherence and persistence to therapy, but did not test any new drugs or aim to cure the disease. The goal was to gather real-world data on treatment habits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA IN RELAPSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centrum für Hämatologie und Onkologie Bethanien
Frankfurt, 60389, Germany
Conditions
Explore the condition pages connected to this study.